Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Onglyza set for launch in Japan

July 8, 2013

National Health Research Institutes reports development of SGLT2 inhibitors

July 8, 2013

Alnylam reports phase II data for ALN-TTR02

July 4, 2013

Bioventus acquires rights to Pfizer's bone morphogenetic protein portfolio

July 4, 2013

Janssen Pharmaceutica divulges new stearoyl-CoA desaturase inhibitors

July 3, 2013

FDA approves first nonhormonal therapy for menopause-related vasomotor symptoms

July 3, 2013

Procysbi receives positive CHMP recommendation

July 3, 2013

Resverlogix reports topline data from the ASSURE trial

July 3, 2013

Islet Sciences' chief scientific officer receives grant from JDRF

July 3, 2013

UGP-302 evaluated in animal models of obesity and diabetes

July 2, 2013

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...